These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2899440)

  • 1. Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.
    D'Onofrio C; Perno CF; Mazzetti P; Graziani G; Calio' R; Bonmassar E
    Br J Cancer; 1988 May; 57(5):481-8. PubMed ID: 2899440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.
    D'Onofrio C; Pesce CD; Fontana T; Ciprani F; Bonmassar E; Caliŏ R
    Cancer Immunol Immunother; 1990; 31(4):213-20. PubMed ID: 2116232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low concentrations of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture.
    Pesce CD; Ciprani F; D'Onofrio C; Alvino E; Perno CF; Bonmassar E; Caliò R
    Antiviral Res; 1987 Dec; 8(5-6):247-60. PubMed ID: 2897831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.
    D'Onofrio C; Franzese O; Ricci F; Bonmassar E
    Int J Immunopharmacol; 1993 Feb; 15(2):125-36. PubMed ID: 8468116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures.
    D'Onofrio C; Alvino E; Garaci E; Bonmassar E; Santoro MG
    Br J Cancer; 1990 Feb; 61(2):207-14. PubMed ID: 2310673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection.
    Macchi B; Popovic M; Allavena P; Ortaldo J; Rossi P; Gallo RC; Bonmassar E
    Int J Cancer; 1987 Jul; 40(1):1-6. PubMed ID: 2885278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortalization of human T lymphocytes by HTLV-I: phenotypic characteristics of target cells and kinetics of virus integration and expression.
    Del Mistro A; De Rossi A; Aldovini A; Salmi R; Chieco-Bianchi L
    Leuk Res; 1986; 10(9):1109-20. PubMed ID: 3020320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.
    Smith D; Buckle GJ; Hafler DA; Frank DA; Höllsberg P
    Virology; 1999 May; 257(2):314-21. PubMed ID: 10329542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
    Mitsuya H; Jarrett RF; Cossman J; Cohen OJ; Kao CS; Guo HG; Reitz MS; Broder S
    J Clin Invest; 1986 Nov; 78(5):1302-10. PubMed ID: 2877011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma antigens downmodulate the in vitro inflammatory response in individuals infected with human T cell lymphotropic virus type 1.
    Lima LM; Santos SB; Oliveira RR; Cardoso LS; Oliveira SC; Góes AM; Loukas A; Carvalho EM; Araújo MI
    Neuroimmunomodulation; 2013; 20(4):233-8. PubMed ID: 23752304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro.
    Graziani G; Pasqualetti D; Lopez M; D'Onofrio C; Testi AM; Mandelli F; Gallo RC; Bonmassar E
    Blood; 1987 Apr; 69(4):1175-81. PubMed ID: 2881587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
    Castro I; Giret TM; Magnani DM; Maxwell HS; Umland O; Perry JK; Pecotte JK; Brasky KM; Barber GN; Desrosiers RC; Watkins DI
    J Virol; 2016 Jun; 90(11):5280-5291. PubMed ID: 26984729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV).
    De Vecchis L; Graziani G; Macchi B; Grandori C; Pastore S; Popovic M; Gallo RC; Bonmassar E
    Leuk Res; 1985; 9(3):349-55. PubMed ID: 2987620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV.
    Mann DL; Popovic M; Murray C; Neuland C; Strong DM; Sarin P; Gallo RC; Blattner WA
    J Immunol; 1983 Oct; 131(4):2021-4. PubMed ID: 6311905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle progression and apoptosis in K562 and Molt-4 cells after cell-to-cell transmission of HTLV-I: modulation by interferons.
    D'Onofrio C; Puglianiello A; Lanzilli G; Peci E; Starace G; Bonmassar E
    Cell Death Differ; 1995 Jan; 2(1):57-68. PubMed ID: 17180016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I.
    Macchi B; D'Onofrio C; Labianca RA; Bonmassar E
    Pharmacol Res; 1990; 22(4):503-14. PubMed ID: 2205849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.
    Macchi B; Faraoni I; Mastino A; D'Onofrio C; Romeo G; Bonmassar E
    Cancer Immunol Immunother; 1993 Jul; 37(2):97-104. PubMed ID: 8100486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP70 production and inhibition of cell proliferation in Molt-4 T-cells after cell-to-cell transmission of HTLV-I: effect of PGA1.
    D'Onofrio C; Puglianiello A; Amici C; Faraoni I; Lanzilli G; Bonmassar E
    Leuk Res; 1995 May; 19(5):345-56. PubMed ID: 7769835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.